KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Interest & Investment Income (2016 - 2025)

Exact Sciences (EXAS) has disclosed Interest & Investment Income for 16 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 27.01% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.8 million, a 5.59% increase, with the full-year FY2025 number at $41.8 million, up 5.59% from a year prior.
  • Interest & Investment Income was $7.3 million for Q4 2025 at Exact Sciences, down from $17.6 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $31.2 million in Q1 2021 to a low of -$8.6 million in Q3 2022.
  • A 5-year average of $6.3 million and a median of $4.9 million in 2023 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: soared 32052.58% in 2021, then plummeted 549.36% in 2022.
  • Exact Sciences' Interest & Investment Income stood at $1.3 million in 2021, then tumbled by 549.36% to -$5.6 million in 2022, then skyrocketed by 549.51% to $25.3 million in 2023, then crashed by 60.67% to $10.0 million in 2024, then dropped by 27.01% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Interest & Investment Income are $7.3 million (Q4 2025), $17.6 million (Q3 2025), and $11.9 million (Q2 2025).